On the morning of December 5, 2018, a delegation of nine representatives from Russian pharmaceutical companies Interbiomed and Euroservice visited DiQi Pharmaceuticals Co., Ltd for an inspection and exchange under the guidance of the Guangzhou Bioindustry Alliance. Accompanied by Peng Tangseng, Deputy General Manager of DiQi Pharmaceuticals Co., Ltd, the visiting delegation toured the company's honor display wall, laboratories, and office areas.

Subsequently, both parties held an exchange meeting in the conference room. Interbiomed, a pharmaceutical manufacturer, sought to establish partnerships in Guangzhou, including the commercialization of new drug R&D achievements and assisting Guangzhou-based companies in expanding into the Russian market. Euroservice, a medical device distributor, aimed to source high-quality medical products from Guangzhou for entry into the Russian market.

Both companies expressed strong interest in DiQi Pharmaceuticals Co., Ltd's R&D capabilities, quality management system, and product pipeline. Interbiomed stated its desire to maintain close ties with DiQi Pharmaceuticals Co., Ltd in the future, exploring broad cooperation in areas such as translating new drug R&D achievements into commercialization and expanding into the Russian market.